Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Lawmakers hear competing views on 340B transparency bill as hospitals warn of burden
Summary
HB 17‑55 would require expanded reporting and enforcement around the federal 340B drug‑pricing program. The bill’s sponsor said it would bring sunlight to alleged abuses; hospitals and FQHCs warned state rules could duplicate HRSA oversight and risk program participation. DHHS and the Attorney General’s Charitable Trust Unit offered to supply more data for committee review.
Representative Yuri Polozov told the committee HB 17‑55 seeks transparency and accountability for New Hampshire entities participating in the federal 340B drug‑pricing program, saying some hospitals may benefit financially without commensurate charity care. He cited national reports alleging that hospitals have sometimes charged patients collection fees while retaining 340B savings, and he argued a sunshine and enforcement approach — including more reporting and the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
